The Romanian Competition Authority opens an investigation into possible abuse of dominant position and restriction on market entry by a pharmaceutical company in the medicines market (Boehringer Ingelheim)

The Competition council opened an investigation on medicine market* • Possible abuse of dominant position of Boehringer Ingelheim RCV Gmbh&CO. KG The Competition Council opened an investigation into a possible abuse of a dominant position of Boehringer Ingelheim RCV GmbH & Co. KG. KG, Vienna, on the Romanian market for the sale of direct oral anticoagulant medicines and medicines for the treatment of chronic obstructive pulmonary disease. The competition authority has indications that Boehringer Ingelheim RCV GmbH & Co. has

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Romanian Competition Authority, The Romanian Competition Authority opens an investigation into possible abuse of dominant position and restriction on market entry by a pharmaceutical company in the medicines market (Boehringer Ingelheim), 6 December 2021, e-Competitions December 2021, Art. N° 106100

Visites 170

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues